To determine whether JP4-039 mitigates AKI by suppressing tubular cell injury in cisplatin-treated mice, we co-stained kidney sections with antibodies against the kidney tubular injury marker, i.e., kidney injury molecule-1 (Kim1) and the proximal tubule marker Lotus tetragonolobus lectin (LTL). Here, HAVCR1 is linked to acute kidney injury.